Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 4, 2012, Pages 351-353

  Akin, Mehmet ^a  

^a DENIZLI STATE HOSPITAL   (Turkey)

Author keywords

children; parent; von Willebrand disease; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CHILD; CHILD PARENT RELATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FAMILY; FEMALE; HUMAN; LABORATORY TEST; LOW LEVEL VON WILLEBRAND DISEASE; MALE; MILD TYPE 1 VON WILLEBRAND DISEASE; PARENT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGE; HUMANS; MALE; PEDIGREE; VON WILLEBRAND DISEASE, TYPE 1; VON WILLEBRAND FACTOR;

EID: 84861041965     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835274f1     Document Type: Article

References (15)

1. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Working party on von Willebrand disease classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemost 2006;4:2103-2114.
2. Favaloro EJ, Thom J, Baker R, on behalf of the Australasian Society for Thrombosis and Haemostasis (ASTH) Emerging Technologies Group. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multilaboratory survey. Blood Coagul Fibrinolysis 2000;11:729-738.
3. Sadler JE. LowvonWillebrand factor: sometimes a risk factor and sometimes a disease. Hematol Am Soc Hematol Educ Program 2009;106-112.
4. Akin M, Kavakli K. Laboratory diagnosis and management of von Willebrand disease in Turkey: Izmir experience. Semin Thromb Hemost 2011;37:581-586.
5. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008;14:171-232.
6. Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, et al. Characterization, classification, and treatment of Von Willebrand disease: a critical appraisal of the literature and personal experiences. Semin Thromb Hemost 2005;31:577-601.
7. Akin M, Karapinar YD, Balkan C, Ay Y, Kavakli K. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children. Clin Appl Thromb Hemost 2011;17:441-448.
8. James PD, Notley C, Hegadorn C, Leggo J, Tuttle A, Tinlin S, et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007;109:145-154.
9. Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007;109:112-121.
10. Eikenboom J, van Marion V, Putter H, Goodeve A, Rodeghiero F, Castaman G, et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD). J Thromb Haemost 2006;4:774-782.
11. Favaloro EJ. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays. Blood Coagul Fibrinolysis 2011;22:553-564.
12. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrands disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003;88:94-108.
13. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs. the potential association with risk of thrombosis. Am J Clin Pathol 2005;124:910-917.
14. Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 2003;1:2191-2197.
15. Akin M, Balkan C, Karapinar YD, Kavakli K. The Influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms (published online 23 September). Clin Appl Thromb Hemost 2011.